Dariohealth Stock News

Equities research analysts expect DarioHealth Corp. (NASDAQ:DRIO) to post $5.95 million in sales for the current quarter, according to Zacks. Two analysts have made estimates for DarioHealths earnings. The highest sales estimate is $6.10 million and the lowest is $5.80 million. DarioHealth reported sales of $2.04 million in the same quarter last year, which indicates []

DarioHealth (NASDAQ:DRIO) reported its Q3 earnings results on Monday, November 15, 2021 at 04:30 PM. Here's what investors need to know about the announcement.

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences. Among the

DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement.

NEW YORK, Nov. 8, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the third quart

NEW YORK, Nov. 5, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate at the following conferen

BOSTON, Oct. 18, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today the launch of Dario Move, a new digital physical thera

The stock price of DarioHealth Corp (NASDAQ: DRIO) increased by over 10% pre-market today. This is why it happened.

NEW YORK, Oct. 14, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it has entered into an agreement with one of the lar

NEW YORK, Oct. 7, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today an agreement with a global company based in the Unite

NEW YORK, Sept. 24, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate in a fireside chat duri

NEW YORK, Sept. 17, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company's Chief Medical Officer, Dr. Omar Mane

Dario Continues to Expand its Employer Contracts Across Broad Range of Solutions NEW YORK, Sept. 9, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (

NEW YORK, Sept. 8, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into an agreement to provide it

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has finalized a contract with PeopleOne Health to be the digital behavioral health solution of choice for patients effe